Development and Evaluation of an Evidence-based Education Program for People With Hand Dysfunction in Scleroderma
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this study is to develop an evidence-based educational program for scleroderma patients with hand dysfunction. The program includes a self-care handbook and multimedia video resources. The study aims to answer: Does the intervention improve hand function in the experimental group compared to the control group? Does the intervention improve self-care knowledge of hand dysfunction? Does the intervention improve overall health? Participants will receive an 8-week program, while the control group receives usual care. Outcome measures include hand function, overall health, and self-care knowledge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 30, 2024
CompletedFirst Submitted
Initial submission to the registry
November 16, 2024
CompletedFirst Posted
Study publicly available on registry
November 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedNovember 20, 2024
November 1, 2024
11 months
November 16, 2024
November 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Self-developed questionnaire on self-care knowledge for scleroderma hand dysfunction
The "Scleroderma Hand Function-Related Self-Care Knowledge Scale," validated by experts for reliability and validity, consists of 15 items. The scale uses a dichotomous scoring method with three response options: "True," "False," and "Don't know." It includes both positively and negatively worded items. Correct answers are scored as one point, while incorrect answers and "Don't know" responses are scored as zero. The total score ranges from 0 to 15, with higher scores indicating a greater level of self-care knowledge regarding scleroderma-related hand function impairments.
At baseline, 4 weeks, and 8 weeks post-intervention
Grip strength
Grip strength of the dominant hand (in kg) will be measured using a dynamometer, and the average of three trials will be used as the final muscle strength assessment indicator.
At baseline, 4 weeks, and 8 weeks post-intervention.
delta finger-to-palm, Delta-FTP
Delta-FTP refers to the difference in distance between the tip of the third finger and the midpoint of the distal palmar crease when the finger is fully extended and fully flexed. It is an effective measurement method to assess the range of motion and flexibility of fingers in patients with scleroderma.
At baseline, 4 weeks, and 8 weeks post-intervention.
Raynaud's phenomenon visual analog scale
This scale evaluates the severity and impact of Raynaud's phenomenon on daily activities in patients with scleroderma over the past week. Scores range from 0 mm (no impact) to 100 mm (very severe impact), with higher scores indicating greater impairment of hand function
At baseline, 4 weeks, and 8 weeks post-intervention.
Digital ulcers visual analog scale
This scale evaluates the severity and impact of Digital ulcers on daily activities in patients with scleroderma over the past week. Scores range from 0 mm (no impact) to 100 mm (very severe impact), with higher scores indicating greater impairment of hand function.
At baseline, 4 weeks, and 8 weeks post-intervention.
Secondary Outcomes (2)
Overall disease severity visual analog scale
At baseline, 4 weeks, and 8 weeks post-intervention
Adherence to Hand Exercise Training
At baseline, 4 weeks, and 8 weeks post-intervention.
Study Arms (2)
Patient education group
EXPERIMENTALreceives the "Evidence-Based Education Program for people with hand dysfunction in scleroderma" (which includes: educational handbook on self-care for hand dysfunction in scleroderma, multimedia teaching materials, and individualized consultations).
control group
NO INTERVENTIONReceives usual care
Interventions
The intervention for the experimental group was an "evidence-based educational program for hand dysfunction in patients with systemic sclerosis," which included a health education manual and multimedia videos developed through evidence translation. Additionally, individual education and consultation were provided.
Eligibility Criteria
You may qualify if:
- Participants with systemic sclerosis who meet the 2013 American College of Rheumatology (ACR) / European League Against Rheumatism (EULAR) diagnostic criteria and have hand dysfunction.
- Adults aged 18 years or older.
- Participants who are conscious and able to communicate in Mandarin Chinese or Taiwanese Hokkien.
- Participants who provide informed consent to participate in the study after being briefed on its purpose.
You may not qualify if:
- \. Participants who have participated in any other hand rehabilitation program within the past three months.
- , Participants with organic brain dysfunction. 3. Participants with severe visual or hearing impairments. 4. Participants with serious illnesses that hinder communication or interfere with the normal learning process.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wen-Shao Linlead
- Cheng Hsin Rehabilitation Medical Centercollaborator
- National Taipei University of Nursing and Health Sciencescollaborator
Study Sites (1)
Cheng Hsin General Hospital
Taipei, 112, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cheng Hsin General Hospital
Institutional Review Board
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Nurse Practitioner
Study Record Dates
First Submitted
November 16, 2024
First Posted
November 20, 2024
Study Start
July 30, 2024
Primary Completion
June 30, 2025
Study Completion
July 31, 2025
Last Updated
November 20, 2024
Record last verified: 2024-11